Onyx Pharmaceuticals Inc (NASDAQ:ONXX)
| 94.34 Data as of May 20 |  -1.31 / -1.37%Today’s Change | 41.26 Today|||52-Week Range 101.57 | +24.90% Year-to-Date |
Latest ONXX News | Press Releases
| Aveo Screwed Up but Its Kidney Cancer Drug Is Real May 15 / TheStreet.com | Narrower Loss from Onyx, Guidance Maintained - Analyst Blog May 08 / Zacks.com |
| Wider-than-Expected Loss at ChemoCentryx - Analyst Blog May 14 / Zacks.com | Mid-week Update – 05/08/2013 May 08 / StockTwits |
| Good News for Cubist Pharmaceuticals - Analyst Blog May 09 / Zacks.com | Wider-than-Expected Loss at Corcept - Analyst Blog May 07 / Zacks.com |
| Narrower-than-Expected Loss at ArQule - Analyst Blog May 09 / Zacks.com | Valeant Misses Earnings and Revenue Estimate in 1Q (Revised) - Analyst Blog May 07 / Zacks.com |
Today’s Trading
| Previous close | 95.65 |
| Today’s open | 95.55 |
| Day’s range | -- - -- |
| Volume | 1,057,283 |
| Average volume (3 months) | 1,255,554 |
| Market cap | $7.0B |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/20/2013
Growth & Valuation
| Earnings growth (last year) | -342.02% |
| Earnings growth (this year) | +31.89% |
| Earnings growth (next 5 years) | +36.70% |
| Revenue growth (last year) | -19.01% |
| P/E ratio | NM |
| Price/Sales | 13.59 |
| Price/Book | 7.87 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RDYDr.Reddy's Laborator... | -0.27 | -0.71% |
| PCYCPharmacyclics Inc | -3.03 | -3.57% |
| ELNElan Corporation PLC | +0.37 | +3.17% |
| HSPHospira Inc | +0.29 | +0.81% |
Data as of 4:04pm ET, 05/20/2013
Financials
| Next reporting date | August 6, 2013 |
| EPS forecast (this quarter) | -$0.45 |
| Annual revenue (last year) | $362.2M |
| Annual profit (last year) | -$187.8M |
| Net profit margin | -51.85% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer N. Anthony Coles, Jr., MD |
Chief Financial Officer & Executive Vice President Matthew K. Fust, MBA |
Corporate headquarters South San Francisco, California |
Forecasts
